SUMMARY Biliary lipid secretion rates, faecal steroids, and serum lipids were studied in patients with chronic cholestatic liver disease mainly primary biliary cirrhosis. The biliary secretion of cholesterol, bile acids, and phospholipids was markedly decreased as compared with those in the control group and in general correlated negatively with the serum cholesterol and triglyceride values. The molar percentage of cholesterol was increased in the hepatic bile. This suggests that, in cholestatic liver disease, in contrast with the normal state, the hepatic bile may be supersaturated postprandially. Faecal bile acids and neutral sterols of cholesterol origin were decreased proportionately to the corresponding biliary lipid secretion rates. In fact, both biliary and faecal steroid outputs were only about a half or less than those in the controls, indicating that the fractional absorption was not changed but absolute absorption and faecal steroid excretion were low in patients with chronic cholestatic liver disease. Thus, despite low cholesterol and bile acid absorption, cholesterol and bile acid synthesis is low. A negative correlation between faecal steroids and serum cholesterol suggests that the high serum cholesterol level contributed to regulation of cholesterol synthesis.
Marked abnormalities in cholesterol and bile acid metabolism have been reported in patients with severe chronic liver diseases. In non-cholestatic cirrhosis the production of cholesterol holding capacity of the bile is higher than in control subjects.2 In liver failure in general the biological half-life of bile acids is prolonged, the pool size diminished, and the synthesis of bile acids is markedly reduced. 5 Our previous studies on biliary lipid composition and faecal steroid excretion suggested that the patients with severe forms of chronic active hepatitis and primary biliary cirrhosis have a low biliary lipid secretion, resulting in decreased faecal steroid output.6 7 With this background the present study was designed to obtain more detailed information on the hourly biliary secretion rates of cholesterol, bile acids and phospholipids in patients with chronic cholestatic liver disease. This is of particular interest as the prevalence of gall stones is increased in patients with cirrhosis of the liver.8
The series included eight patients with variable severity of primary biliary cirrhosis, one patient with a cholestatic form of chronic active hepatitis, and one patient with sclerosing cholangitis. Six was prepared by sonication from 20 ml olive oil, 20 g fat-free milk powder, 4.5 g glycerol-1-mono-oleate (Fluka SG, Switzerland) and 200 ml water. The energy content of the formula was 1.3 kcal/ml. The formula contained 4 g polyethylene glycol 4000 (Fluka AG, Switzerland) as a non-absorbable marker. The formula with markers was infused at a rate of 30 ml/h into the duodenum via the proximal outlet of the tube with an infusion pump. Samples of 5-10 ml were aspirated hourly through outlets, which were located 15-20 cm more distally in the duodenum. Collections were performed up to six to eight hours. The samples obtained were placed in a water bath at 70°C for five minutes to destroy the lipase activity and stored at -20°C until analysed. The biliary secretion rates of cholesterol, bile acids, and phospholipids into the duodenum were calculated according to Grundy 
Results

SERUM LIPIDS
The mean serum cholesterol and triglyceride levels were significantly raised in the patients with chronic cholestatic liver disease (Table 1) . Only a few patients, however, had a marked hypercholesterolaemia and only three patients were actually hypertriglyceridaemic.
BILIARY LIPIDS
The mean biliary secretion rates of cholesterol, bile acids and phospholipids were in the patients only 52, 38, 35%, respectively, of those in the controls ( Table 2 ). The hourly secretion rates of bile acids correlated significantly with those of cholesterol and phospholipids in both groups (Fig. 1) . The mean molar percentage of cholesterol was markedly raised in the hepatic bile of the patients. The molar percentage plotted against the respective hourly output of bile acids (Fig. 2) showed a negative correlation in both groups and demonstrates the high molar percentage of cholesterol (supersaturation) at the low bile acid output in the patients. At higher bile acid secretion rates, however, around 10 ,umol kg-'h-', for instance, the molar percentage of cholesterol tends to be even lower in the patients than in the controls.
The plot of the biliary lipid secretion rates against the liver function tests of Table 1 biliary cholesterol (r=0.70; p<002; n=10) and negatively with that of biliary bile acids (r= -0.67; p<002; n=10). The biliary lipid secretion rates in general correlated negatively with serum cholesterol and triglyceride values (Table 3 ). In addition, the molar percentages of biliary bile acids correlated negatively (r=0.61; p<0.01; n=17) and those of biliary cholesterol (r=0.55; p<005; n=17) and The mean faecal fat was higher in the patient group than in the controls. An increased faecal fat (7 g/day) was found, however, in three patients only (Table 2) .
BILE ACID SECRETION, pimol kg-lhrK1 The daily output of faecal bile acids, neutral steroids, and total steroids was significantly lower in the patients than in the controls. The mean respective values were only 56, 40, and 52% of those in the controls.
The correlations in Table 3 and Fig. 3 indicate that, in general, the lower the faecal steroid excretion the lower also was the biliary lipid secretion rate and the higher were the serum cholesterol and triglyceride levels. Thus, hypercholesterolaemia and hypertriglyceridaemia were suggested low biliary lipid secretion rates in the severe forms of these diseases.6 7 Direct measurements of the biliary lipid secretion rate in the present study on patients with varying severity of mainly primary biliary cirrhosis show this suggestion to be true. In contrast, however, with the observations on the low molar percentage of cholesterol in the fasting gall bladder bile2 b7 the hepatic bile obtained during the hepatic secretion exhibited a high molar percentage (12.5% vs. 7.9% in the controls) in the present patients. In addition, fasting gall bladder bile samples were previously analysed and reported (7) for six of the patients of the present study (patients nos 1, 2, 4, 5, 6, and 9).
The molar percentage of cholesterol for these six patients was significantly higher in the hepatic bile of the present study (8.6%±*09 (SEM) ) than in the fasting gall bladder bile of our previous study (5.6%±0.9) (7) (p<0-025, paired t test). Thus, in severe cholestatic liver disease the hepatic bile appears to be strongly supersaturated during active enterohepatic circulation of bile acids mainly because bile acids are retained in the circulation. During night time and during the fasting state in general the hepatic bile of these patients is apparently less saturated with cholesterol, resulting in the low molar percentage in the gall bladder bile. In cholestatic liver disease the situation may thus be inverse to the normal state in which the hepatic bile is supersaturated in fasting state and undersaturated postprandially. Therefore, the situation differs from that in the patients with moderately advanced alcoholic cirrhosis26 in which the biliary lipid secretion rates are not disturbed and the molar percentages of cholesterol are normal both in the gall bladder bile and in hepatic bile obtained during biliary secretion measurements. In severe alcoholic cirrhosis, in which the biliary lipid secretion is low, the cholesterol saturation of the gall bladder bile is low but appears to be normal (molar % cholesterol 5.2 vs 4.3 in the controls) during biliary lipid secretion measurements. 26 The finding of low fasting and high postprandial cholesterol saturation of bile in patients with chronic liver disease may be clinically important. The prevalence of gall stones is increased in patients with cirrhosis of the liver.8 In contrast, however, with the general population where the majority of gall stones are of the cholesterol type28 cirrhotic patients have principally pigment stones.29 30 Therefore, it is possible that the inverse situation of supersaturated postprandial and undersaturated fasting bile observed in the patients of the present study is actually beneficial in the prevention of cholesterol gall stone formation in patients with liver disease and low biliary lipid secretion.
Ordinary liver function tests are weakly associated with biliary lipid secretion in patients with chronic cholestatic liver disease. Significant correlations were observed, however, between the serum cholesterol and triglyceride values on the one hand and the biliary and faecal steroid outputs on the other hand. Thus, in general, the development of hyperlipidaemias appears to be associated with impaired biliary and faecal steroid output in cholestatic liver disease.
Faecal bile acids and neutral sterols of cholesterol origin have been reported to be decreased in patients with chronic cholestatic liver disease' 6 7 and these findings were confirmed in the present study. Urinary bile acids are frequently raised,' 31 but this route of bile salt elimination is minor compared with faecal excretion.' This indicates that bile acid and cholesterol synthesis are decreased in patients with cholestatic liver disease, a finding supported by earlier observations.' 7 The positive correlation of faecal steroid outputs with the biliary lipid secretion rates suggests that low biliary secretion of cholesterol and bile acids determined mainly the low faecal excretion and not the increased fractional absorption of these steroids. In fact, as compared with the controls the biliary secretion rates and faecal steroid excretion were decreased by about a factor of two, as if the relative absorption had been unchanged. Calculations of the relative absorption of both bile acids (96.5%) and cholesterol (25.4%) ( 
